Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  'Merck'
Latest

Judge: Amgen will not have to put drug prices in TV ads

By   /  Tuesday, June 16th, 2020  /  Biotech, East Ventura County, Latest news, Law, Technology  /  Comments Off on Judge: Amgen will not have to put drug prices in TV ads

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Atara Biotherapeutics reports $58 million net loss

By   /  Tuesday, November 6th, 2018  /  Biotech, Central Coast Health Watch, Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Atara Biotherapeutics reports $58 million net loss

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

SerImmune gets $8 million in financing from Illumina Ventures

By   /  Thursday, June 22nd, 2017  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on SerImmune gets $8 million in financing from Illumina Ventures

Santa Barbara immunotherapy and diagnostic company SerImmune received $8 million in financing from San Francisco-based Illumina Ventures to expand its immune mapping platform and database. Illumina invests primarily in early-stage companies researching genomics, life science and health care. A subsidiary of pharmaceutical giant Merck also participated in the financing round, alongside other undisclosed investors. Mapping Read More →

Read More →
Latest

Agilent cancer treatment approved in Europe

By   /  Thursday, February 2nd, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Agilent cancer treatment approved in Europe

Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →

Read More →
Latest

Amgen spends big to defeat Proposition 61

By   /  Friday, October 14th, 2016  /  Central Coast Health Watch, Law, Top Stories, Top Story  /  Comments Off on Amgen spends big to defeat Proposition 61

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen seeks European OK of biosimilar drug, partners with Merck on studies

By   /  Friday, December 4th, 2015  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen seeks European OK of biosimilar drug, partners with Merck on studies

Amgen announced two developments Dec. 4 that should help the Thousand Oaks-based biotech giant compete. Amgen said it is seeking approval from the European Medicines Agency for ABP 501, a biosimilar drug similar to Humira. Amgen also announced a partnership with New Jersey-based pharmaceutical Merck to partner in a non-Hodgkins lymphoma study using drugs from Read More →

Read More →